Postoperative survival of EGFR-TKI-targeted therapy in non-small cell lung cancer patients with EGFR 19 or 21 mutations: a retrospective study
Crossref DOI link: https://doi.org/10.1186/s12957-017-1251-z
Published Online: 2017-11-06
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yang, Wenjing
Gao, Yibo
Li, Xuelian
Zhang, Jing
Liu, Tiejun
Feng, Xiaoli
Pan, Hao
Yang, Xiaofan
Xie, Shuanghua
Feng, Xiaoshuang
Lv, Zhangyan
Wang, Yonggang
Chen, Zhaoli
He, Jie https://orcid.org/0000-0002-5505-9793